Fecal corticosterone levels in RCAN1 mutant mice

Comparative Medicine

Volumn 62, Issue 2, 2012, Pages 87-94

  Rakowski Anderson, Tammy ^a   Wong, Helen ^a,b   Rothermel, Beverly ^c   Cain, Peter ^d   Lavilla, Carmencita ^a   Pullium, Jennifer K ^a   Hoeffer, Charles ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d EXCELSIOR COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CORTICOSTERONE; PROTEIN REGULATOR OF CALCINEURIN 1; UNCLASSIFIED DRUG; DSCR1 PROTEIN, MOUSE; MUSCLE PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE RELEASE; FECES ANALYSIS; FEMALE; GENE; GENE OVEREXPRESSION; KNOCKOUT MOUSE; MALE; MAZE TEST; MOUSE; MOUSE MUTANT; NERVE CELL; NONHUMAN; PHENOTYPE; REGULATOR OF CALCINEURIN 1 GENE; SEX DIFFERENCE; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; CIRCADIAN RHYTHM; FECES; GENETICS; GENOTYPE; METABOLISM; MOTOR ACTIVITY; MUTATION; PHOTOPERIODICITY; PSYCHOLOGICAL ASPECT; TIME;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; CORTICOSTERONE; FECES; FEMALE; GENOTYPE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; MUSCLE PROTEINS; MUTATION; PHENOTYPE; PHOTOPERIOD; SEX FACTORS; TIME FACTORS;

EID: 84866457472     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Anagnostis P, Athyros VG, Tziomalos K, Karagiannis A, Mikhailidis DP. 2009. Clinical review. The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 94:2692-2701.
2. Anderson SM, Saviolakis GA, Bauman RA, Chu KY, Ghosh S, Kant GJ. 1996. Effects of chronic stress on food acquisition, plasma hormones, and the estrous cycle of female rats. Physiol Behav 60:325-329. (Pubitemid 126335895)
3. Anisman H, Hayley S, Kelly O, Borowski T, Merali Z. 2001. Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: mouse strain-dependent outcomes. Behav Neurosci 115:443-454. (Pubitemid 32378173)
4. Bayazit V. 2009. Evaluation of cortisol and stress in captive animals. Austral J Basic Appl Sci 3:1022-1031.
5. Benno R, Smirnova Y, Vera S, Liggett A, Schanz N. 2009. Exaggerated responses to stress in the BTBR T+tf/J mouse: an unusual behavioral phenotype. Behav Brain Res 197:462-465.
6. Bouwknecht JA, Paylor R. 2008. Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents. Behav Pharmacol 19:385-402.
7. Capone G, Goyal P, Ares W, Lannigan E. 2006. Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet 142C:158-172. (Pubitemid 44298198)
8. Carter RN, Paterson JM, Tworowska U, Stenvers DJ, Mullins JJ, Seckl JR, Holmes MC. 2009. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11β-HSD1 is strain-dependent. J Neuroendocrinol 21:879-887.
9. Cavigelli SA, Monfort SL, Whitney TK, Mechref YS, Novotny M, McClintock MK. 2005. Frequent serial fecal corticoid measures from rats reflect circadian and ovarian corticosterone rhythms. J Endocrinol 184:153-163. (Pubitemid 40207570)
10. Chelini MO, Otta E, Yamakita C, Palme R. 2010. Sex differences in the excretion of fecal glucocorticoid metabolites in the Syrian hamster. J Comp Physiol B 180:919-925.
11. Clark D, Wilson GN. 2003. Behavioral assessment of children with Down syndrome using the Reiss psychopathology scale. Am J Med Genet A 118A:210-216. (Pubitemid 37063928)
12. De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. 1998. Brain corticosteroid receptor balance in health and disease. Endocr Rev 19:269-301. (Pubitemid 29117816)
13. Eriksson E, Royo F, Lyberg K, Carlsson HE, Hau J. 2004. Effect of metabolic cage housing on immunoglobulin A and corticosterone excretion in faeces and urine of young male rats. Exp Physiol 89:427-433. (Pubitemid 39028866)
14. File SE, Mabbutt PS, Hitchcott PK. 1990. Characterisation of the phenomenon of 'one-trial tolerance' to the anxiolytic effect of chlordiazepoxide in the elevated-plus maze. Psychopharmacology (Berl) 102:98-101. (Pubitemid 20227535)
15. Frye CA, Llaneza DC. 2010. Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice. Physiol Behav 100:264-267.
16. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, Estivill X, de la Luna S. 2000. DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9:1681-1690. (Pubitemid 30427005)
17. Handa RJ, Burgess LH, Kerr JE, O'Keefe JA. 1994. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm Behav 28:464-476.
18. Harper JM, Austad SN. 2000. Fecal glucocorticoids: a noninvasive method of measuring adrenal activity in wild and captive rodents. Physiol Biochem Zool 73:12-22. (Pubitemid 30153087)
19. Hoeffer CA, Dey A, Sachan N, Wong H, Patterson RJ, Shelton JM, Richardson JA, Klann E, Rothermel BA. 2007. The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling. J Neurosci 27:13161-13172. (Pubitemid 350220501)
20. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
21. Janssen SF, Twickler TB, Jublanc C, Cramer MJ, Bruckert E. 2008. Patients with the metabolic syndrome and a disturbed cortisol balance display more microalbuminuria. Diab Vasc Dis Res 5:54-58. (Pubitemid 351507347)
22. Kant GJ, Bauman RA, Anderson SM, Mougey EH. 1992. Effects of controllable versus uncontrollable chronic stress on stress-responsive plasma hormones. Physiol Behav 51:1285-1288.
23. Kant GJ, Bauman RA, Feaster SR, Anderson SM, Saviolakis GA, Garcia GE. 2001. The combined effects of pyridostigmine and chronic stress on brain cortical and blood acetylcholinesterase, corticosterone, prolactin and alternation performance in rats. Pharmacol Biochem Behav 70:209-218. (Pubitemid 33049931)
24. Kant GJ, Pastel RH, Bauman RA, Meininger GR, Maughan KR, Robinson TN 3rd, Wright WL, Covington PS. 1995. Effects of chronic stress on sleep in rats. Physiol Behav 57:359-365.
25. Katz ME, Simonetta SH, Ralph MR, Golombek DA. 2008. Immunosuppressant calcineurin inhibitors phase shift circadian rhythms and inhibit circadian responses to light. Pharmacol Biochem Behav 90:763-768.
26. Keating DJ, Chen C, Pritchard MA. 2006. Alzheimer's disease and endocytic dysfunction: clues from the Down syndrome-related proteins, DSCR1 and ITSN1. Ageing Res Rev 5:388-401. (Pubitemid 44437038)
27. Keay JM, Singh J, Gaunt MC, Kaur T. 2006. Fecal glucocorticoids and their metabolites as indicators of stress in various mammalian species: a literature review. J Zoo Wildl Med 37:234-244. (Pubitemid 44521188)
28. Kern W, Dodt C, Born J, Fehm HL. 1996. Changes in cortisol and growth hormone secretion during nocturnal sleep in the course of aging. J Gerontol A Biol Sci Med Sci 51:M3-M9. (Pubitemid 26026951)
29. Li C, Jiang Z, Tang S, Zeng Y. 2007. Influence of enclosure size and animal density on fecal cortisol concentration and aggression in Pere David's deer stags. Gen Comp Endocrinol 151:202-209. (Pubitemid 46413256)
30. Linkowski P, Van Cauter E, Leclercq R, Desmedt D, Brasseur M, Golstein J, Copinschi G, Mendlewicz J. 1985. ACTH, cortisol, and growth hormone 24-hour profiles in major depressive illness. Acta Psychiatr Belg 85:615-623. (Pubitemid 16196470)
31. Markham JA, Beckel-Mitchener AC, Estrada CM, Greenough WT. 2006. Corticosterone response to acute stress in a mouse model of fragile X syndrome. Psychoneuroendocrinology 31:781-785. (Pubitemid 44262253)
32. Mateo JM, Cavigelli SA. 2005. A validation of extraction methods for noninvasive sampling of glucocorticoids in free-living ground squirrels. Physiol Biochem Zool 78:1069-1084. (Pubitemid 41612453)
33. McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY. 2006. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 103:18267-18272. (Pubitemid 44871647)
34. Moore RY, Eichler VB. 1972. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 42:201-206.
35. Mostl E, Palme R. 2002. Hormones as indicators of stress. Domest Anim Endocrinol 23:67-74.
36. Myers BA, Pueschel SM. 1991. Psychiatric disorders in persons with Down syndrome. J Nerv Ment Dis 179:609-613.
37. Oh M, Rybkin II, Copeland V, Czubryt MP, Shelton JM, van Rooij E, Richardson JA, Hill JA, De Windt LJ, Bassel-Duby R, Olson EN, Rothermel BA. 2005. Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. Mol Cell Biol 25:6629-6638. (Pubitemid 41023236)
38. Palme R. 2005. Measuring fecal steroids: guidelines for practical application. Ann N Y Acad Sci 1046:75-80. (Pubitemid 41123864)
39. Park J, Oh Y, Chung KC. 2009. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1. BMB Rep 42:6-15.
40. Pasquali R, Gagliardi L, Vicennati V, Gambineri A, Colitta D, Ceroni L, Casimirri F. 1999. ACTH and cortisol response to combined corticotropin releasing hormone-arginine vasopressin stimulation in obese males and its relationship to body weight, fat distribution, and parameters of the metabolic syndrome. Int J Obes Relat Metab Disord 23:419-424. (Pubitemid 29182402)
41. Pedram A, Razandi M, Aitkenhead M, Levin ER. 2005. Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem 280:26339-26348. (Pubitemid 41022232)
42. Porta S, Serra SA, Huch M, Valverde MA, Llorens F, Estivill X, Arbones ML, Marti E. 2007. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum Mol Genet 16:1039-1050. (Pubitemid 47062725)
43. Pritchett KR, Johnston NA. 2002. A review of treatments for the eradication of pinworm infections from laboratory rodent colonies. Contemp Top Lab Anim Sci 41:36-46. (Pubitemid 135706573)
44. Rachidi M, Lopes C. 2008. Mental retardation and associated neurological dysfunctions in Down syndrome: a consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways. Eur J Paediatr Neurol 12:168-182. (Pubitemid 351545848)
45. Reppert SM, Weaver DR. 2001. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol 63:647-676. (Pubitemid 32304333)
46. Rothermel BA, Vega RB, Williams RS. 2003. The role of modulatory calcineurin-interacting proteins in calcineurin signaling. Trends Cardiovasc Med 13:15-21. (Pubitemid 36120545)
47. Sachan N, Dey A, Rotter D, Grinsfelder DB, Battiprolu PK, Sikder D, Copeland V, Oh M, Bush E, Shelton JM, Bibb JA, Hill JA, Rothermel BA. 2011. Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart. Circ Res 108:437-445.
48. Sachar EJ, Hellman L, Roffwarg HP, Halpern FS, Fukushima DK, Gallagher TF. 1973. Disrupted 24-hour patterns of cortisol secretion in psychotic depression. Arch Gen Psychiatry 28:19-24.
49. Sapolsky RM, Romero LM, Munck AU. 2000. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21:55-89. (Pubitemid 32266068)
50. Sen Y, Aygun D, Yilmaz E, Ayar A. 2008. Children and adolescents with obesity and the metabolic syndrome have high circulating cortisol levels. Neuroendocrinol Lett 29:141-145.
51. Sherman B, Wysham C, Pfohl B. 1985. Age-related changes in the circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab 61:439-443. (Pubitemid 15243951)
52. Smale L, Nunez AA, Schwartz MD. 2008. Rhythms in a diurnal brain. Biol Rhythm Res 39:305-318. (Pubitemid 351346395)
53. Spiegel K, Leproult R, Van Cauter E. 1999. Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435-1439. (Pubitemid 29494756)
54. Stranahan AM, Lee K, Pistell PJ, Nelson CM, Readal N, Miller MG, Spangler EL, Ingram DK, Mattson MP. 2008. Accelerated cognitive aging in diabetic rats is prevented by lowering corticosterone levels. Neurobiol Learn Mem 90:479-483.
55. Sun X, Wu Y, Chen B, Zhang Z, Zhou W, Tong Y, Yuan J, Xia K, Gronemeyer H, Flavell RA, Song W. 2011. Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. J Biol Chem 286:9049-9062.
56. Thanos PK, Cavigelli SA, Michaelides M, Olvet DM, Patel U, Diep MN, Volkow ND. 2009. A noninvasive method for detecting the metabolic stress response in rodents: characterization and disruption of the circadian corticosterone rhythm. Physiol Res 58:219-228.
57. Touma C, Ambree O, Gortz N, Keyvani K, Lewejohann L, Palme R, Paulus W, Schwarze-Eicker K, Sachser N. 2004. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer's disease. Neurobiol Aging 25:893-904. (Pubitemid 38813169)
58. Touma C, Palme R, Sachser N. 2004. Analyzing corticosterone metabolites in fecal samples of mice: a noninvasive technique to monitor stress hormones. Horm Behav 45:10-22. (Pubitemid 38083330)
59. Touma C, Sachser N, Mostl E, Palme R. 2003. Effects of sex and time of day on metabolism and excretion of corticosterone in urine and feces of mice. Gen Comp Endocrinol 130:267-278. (Pubitemid 36207609)
60. Van Cauter E, Leproult R, Kupfer DJ. 1996. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81:2468-2473. (Pubitemid 26240262)
61. Villar D, Cray C, Zaias J, Altman NH. 2007. Biologic effects of fenbendazole in rats and mice: a review. J Am Assoc Lab Anim Sci 46:8-15. (Pubitemid 351183372)
62. Vogelzangs N, Beekman AT, Dik MG, Bremmer MA, Comijs HC, Hoogendijk WJ, Deeg DJ, Penninx BW. 2009. Late-life depression, cortisol, and the metabolic syndrome. Am J Geriatr Psychiatry 17:716-721.